Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$1.33B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$781M |
| 3 |
Tesla
TSLA
|
+$468M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$467M |
| 5 |
Home Depot
HD
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.36B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$860M |
| 3 |
Bank of America
BAC
|
+$413M |
| 4 |
Advanced Micro Devices
AMD
|
+$283M |
| 5 |
Salesforce
CRM
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.2% |
| 2 | Consumer Discretionary | 1.94% |
| 3 | Communication Services | 1.89% |
| 4 | Healthcare | 1.12% |
| 5 | Financials | 1.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
DuPont de Nemours
DD
$18.3B
| $24.8M | 0.01% |
308,109
+198,035
| +180% | +$16.4M |
|
1227
Ascendis Pharma A/S
ASND
$16.6B
| $24.8M | 0.01% |
178,161
-4,562
| -2% | -$507K |
|
1228
Atlassian
TEAM
$42.7B
| $24.7M | 0.01% |
205,614
-57,918
| -22% | -$7.05M |
|
|
ABMD
1229
DELISTED
Abiomed Inc
ABMD
| $24.7M | 0.01% |
144,891
+51,702
| +55% | +$9.59M |
|
1230
PUT
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$735M
| $24.7M | 0.01% |
21,475
-215
| -1% | -$193K |
|
1231
Lam Research
LRCX
$390B
| $24.7M | 0.01% |
843,060
+337,720
| +67% | +$8.97M |
|
|
1232
CALL
Ascendis Pharma A/S
ASND
$16.6B
| $24.5M | 0.01% |
176,000
-218,900
| -55% | -$24.3M |
|
1233
CALL
Thor Industries
THO
$4.12B
| $24.5M | 0.01% |
329,300
-2,300
| -0.7% | -$148K |
|
1234
CALL
Vertex Pharmaceuticals
VRTX
$140B
| $24.4M | 0.01% |
111,500
-200,200
| -64% | -$40.5M |
|
|
RETA
1235
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $24.4M | 0.01% |
119,400
+15,500
| +15% | +$2.83M |
|
1236
PUT
Dropbox
DBX
$7.54B
| $24.4M | 0.01% |
1,362,800
+545,400
| +67% | +$10.3M |
|
1237
Waste Management
WM
$90B
| $24.3M | 0.01% |
213,644
+90,184
| +73% | +$10.2M |
|
1238
CALL
Scorpio Tankers
STNG
$3.87B
| $24.3M | 0.01% |
618,200
+127,100
| +26% | +$4.35M |
|
1239
PUT
CRISPR Therapeutics
CRSP
$5.93B
| $24.3M | 0.01% |
398,800
+197,400
| +98% | +$10.8M |
|
1240
Pan American Silver
PAAS
$22B
| $24.3M | 0.01% |
1,024,477
-609,626
| -37% | -$11.3M |
|
1241
Cheniere Energy
LNG
$57.9B
| $24.2M | 0.01% |
396,795
+64,203
| +19% | +$3.95M |
|
1242
Marathon Petroleum
MPC
$101B
| $24.2M | 0.01% |
401,813
-668,589
| -62% | -$41.8M |
|
1243
Bunge Global
BG
$20.9B
| $24.2M | 0.01% |
419,960
+50,392
| +14% | +$2.79M |
|
1244
CALL
Enterprise Products Partners
EPD
$82.5B
| $24.2M | 0.01% |
857,900
-116,900
| -12% | -$3.17M |
|
1245
CALL
Planet Fitness
PLNT
$3.95B
| $24.2M | 0.01% |
323,400
-272,800
| -46% | -$18.4M |
|
|
LNW
1246
DELISTED
Light & Wonder
LNW
| $24.1M | 0.01% |
900,132
+207,127
| +30% | +$5.33M |
|
1247
CALL
ArcelorMittal
MT
$55B
| $24.1M | 0.01% |
1,373,100
+203,500
| +17% | +$3.3M |
|
1248
Regeneron Pharmaceuticals
REGN
$86.2B
| $24M | 0.01% |
63,969
-198,283
| -76% | -$66.7M |
|
1249
PUT
Devon Energy
DVN
$52.3B
| $24M | 0.01% |
922,400
+236,700
| +35% | +$5.33M |
|
1250
PUT
Aptiv
APTV
$9.58B
| $23.9M | 0.01% |
252,100
+70,700
| +39% | +$6.47M |
|
Similar funds
Jeff Yass's Q4 2019 Portfolio in Review
As of Q4 2019, Jeff Yass held 11,328 positions worth $347B, up 16% from $298B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass deployed $12.7B of net new capital in Q4 2019, opening 1,232 new positions and adding to 3,827 existing holdings. Its largest new stake was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.
By sector, the portfolio is most concentrated in Technology at 2.2% of assets, up from 2.1% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Amazon, an estimated $1.36B trimmed.
- Jeff Yass's largest Q4 2019 buy was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.
- Jeff Yass added most to Boeing in Q4 2019, an estimated $1.33B increase.
- Jeff Yass's biggest Q4 2019 reduction was Amazon, cutting an estimated $1.36B.
- Jeff Yass fully exited Celgene Corp in Q4 2019, selling an estimated $164M.
- Jeff Yass's ten largest holdings make up 26% of its $347B portfolio in Q4 2019.
- Jeff Yass opened 1,232 new positions and closed 1,709 in Q4 2019.
- Jeff Yass's portfolio value rose 16% quarter-over-quarter to $347B.
Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.